Related Experiment Video
Updated: Jun 8, 2026
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives
Benjamin Lallemant1, Alexandre Evrard, Guillaume Chambon
1Service d'ORL et Chirurgie maxillo-faciale, Centre Hospitalier Universitaire de Nîmes, Place du Pr. Robert Debre, 30029 Nîmes Cedex 9, France. benjamin.lallemant@chu-nimes.fr
Head & Neck
|October 16, 2010
Summary
Gene expression profiling (GEP) in head and neck squamous cell carcinoma (HNSCC) has identified signatures for improved diagnosis, staging, and treatment response prediction. Further validation is needed for clinical application of these molecular markers.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Over 60 gene expression profiling (GEP) studies exist for head and neck squamous cell carcinoma (HNSCC).
- These studies exhibit variability in objectives, methodologies, and outcomes.
Purpose of the Study:
- To provide a comprehensive review of GEP in HNSCC.
- To highlight current advancements and future clinical applications of GEP in HNSCC.
Main Methods:
- Systematic literature review of GEP studies in HNSCC.
- Analysis of identified gene expression signatures and their potential applications.
Main Results:
- GEP signatures aid in identifying screening and diagnostic markers.
- Signatures improve tumor staging, including cervical lymph node and distant metastasis prediction.
- GEP can differentiate HNSCC lung metastasis from primary lung cancer and predict treatment response.
Conclusions:
- Transcriptional signatures show promise for enhancing HNSCC management.
- Further rigorous validation is essential to confirm clinical relevance.
- Large-scale, methodologically sound projects are needed to translate GEP findings into clinical practice.
